Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.

Per September 6, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,289,066 shares, corresponding to 4.97% (previously 5.00%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instruments is 5.01%.

Attachments

• Novozymes B 6 Sept 2024 Final
• 2024_34_Major_Shareholders_Announcement

You May Also Be Interested In

• Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
• RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
• Solana Price Prediction Targets $100 as 150ms Finality Nears and AlphaPepe Builds the Next AI-DeFi Retail Trade